Lands as an active threat. Maybe they're serious about this research or not, but for sure medical companies doing this sort of research will consider upping their AI budget and connecting their labs, etc. to avoid "falling behind".

So, the AI labs benefit either from achieving something they could market or from the peer-pressure imposed to companies in the sectors they get their nose in.